RTOG 0813 SEAMLESS PHASE I/II STUDY OF STEREOTACTIC LUNG RADIOTHERAPY (SBRT) FOR EARLY STAGE, CENTRALLY LOCATED, NON-SMALL CELL LUNG CANCER (NSCLC) IN MEDICALLY INOPERABLE PATIENTS

Objective

Clinical trial of stereotactic body radiation therapy which is investigational.

IRB Protocol Number

09-0413

Principal Investigator(s)

DAVID RABEN

Cancer Trials

• Lung Cancer

Sponsor(s)

RTOG

Contact

ROBYN SWING at 720-848-0607
or ROBYN.SWING@UCDENVER.EDU

Eligibility and Other Participant Information

What To Expect : A screening period to determine eligibility. A treatment period(s) that lasts up to 2 weeks. A follow up period that will consist of a clinic vist at 6 weeks from the start of radiation treatment, every 3 months in years 1-2 and every 6 months in years 3-4, then once a year for your lifetime. // Eligibility criteria include but are not limited to 18 years or older with non-small cell lung cancer.